Presentations
- Stakeholders’ Meeting Presentations (Day)
1 Needs of Patients Affected by the Most Neglected Diseases: A Clinician’s Perspective
by Monique Wasunna, MD, Acting Director, Kenya Medical Research Institute (KEMRI); Head, DNDi Africa
2 DNDi 5 Years On: Achievements and Challenges to Meet Patient Needs
by Bernard Pécoul, MD, MPH, Executive Director, DNDi
3 Advancing R&D Projects Through Partnering
by Shing Chang, PhD, R&D Director, DNDi
4 Mobilizing Small Pharma into a Needs-Driven Consortium to Address HAT
by Yves Ribeill, PhD, President and CEO, SCYNEXIS, USA
5 Uniting Small Pharma Capability Across the World to Address VL
by Rashmi Barbhaiya, PhD, CEO, Advinus Therapeutics, India
6 Creative Utilization of Existing Knowledge to Harness Innovation for the Neglected
by Els Torreele, PhD, Senior Project Manager, DNDi
7 Needs and Challenges in Developing a New Treatment for VL
by Shyam Sundar, MD, Professor of Medicine, Institute of Medical Sciences, Banaras Hindu University, India
8 Challenges in Developing a New Treatment for Chagas Disease
by Sergio Sosa-Estani, MD, MPH, PhD, Head, Service of Epidemiology, National Center for Research on Endemic Diseases/ANLIS, Argentina
- Public Research Symposium Presentations (Evening)
1 DNDi 5 Years On: How the Model Works to Meet Patient Need
by Bernard Pécoul, MD, MPH, Executive Director, DNDi
2 Ensuring a Sustained Commitment to Addressing Neglected Diseases in the Next Generation (transcript)
by Richard Rockefeller, EdM, MD, Chair, Board of Advisors, Doctors Without Borders/Médecins Sans Frontières; Chair, Rockefeller Brothers Fund, USA
